September 2026
M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30

Hilla Ben-Pazi: AMIT301 Receives Approval in Israel for Continuous Stroke Monitoring

Hilla Ben-Pazi/LinkedIn

May 17, 2026, 13:15

Hilla Ben-Pazi: AMIT301 Receives Approval in Israel for Continuous Stroke Monitoring

Hilla Ben-Pazi, Founder and CEO of Avertto Medical LTD, shared on LinkedIn:

”We are excited to share that Avertto has received approval to begin selling AMIT301 in the Israeli market — an important milestone for our company and for the future of continuous stroke monitoring.

AMIT301 is named in memory of the brave paramedic Amit Man, whose dedication to saving lives continues to inspire us every day.

Her legacy lives on through our mission: developing technologies to detect critical cerebrovascular changes earlier and improve patient outcomes.

For those less familiar with the Israeli regulatory pathway, this milestone signifies successful local registration and paves the way for early clinical adoption in Israel.

We are also looking forward to working with our early Israeli adopters, Shady Jahshan, Hillit Cohen, and David Orion, and learning from their feedback as we continue to improve and expand the platform.

It is also a reminder of the strength of the Israeli innovation ecosystem — where medicine, engineering, clinical collaboration, and entrepreneurship come together to transform bold ideas into life-saving technologies.

A huge thank you to our incredible team, Asher Kuper, Kety Bardugo, Yair Lavi, Meron Ben Pazi, and Lior Elmaliach, for the dedication, persistence, and hard work that made this possible.

This achievement belongs to all of you.”

Hilla Ben-Pazi: AMIT301 Receives Approval in Israel for Continuous Stroke Monitoring